[{"id":"ae9f6690-c437-43f1-a5a6-13ec7cf09e5f","acronym":"ZV0203-001CN","url":"https://clinicaltrials.gov/study/NCT05423977","created_at":"2022-06-22T00:55:16.188Z","updated_at":"2024-07-02T16:35:28.620Z","phase":"Phase 1","brief_title":"Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors","source_id_and_acronym":"NCT05423977 - ZV0203-001CN","lead_sponsor":"Hangzhou Adcoris Biopharmacy Co., Ltd","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ADC2122"],"overall_status":"Enrolling by invitation","enrollment":" Enrollment 36","initiation":"Initiation: 12/17/2021","start_date":" 12/17/2021","primary_txt":" Primary completion: 05/05/2023","primary_completion_date":" 05/05/2023","study_txt":" Completion: 07/07/2024","study_completion_date":" 07/07/2024","last_update_posted":"2023-11-20"}]